These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26876733)

  • 21. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
    Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
    Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder inflammatory transcriptome in response to tachykinins: neurokinin 1 receptor-dependent genes and transcription regulatory elements.
    Saban R; Simpson C; Vadigepalli R; Memet S; Dozmorov I; Saban MR
    BMC Urol; 2007 May; 7():7. PubMed ID: 17519035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated arterial calcification and enhanced myogenic response are associated with abcc6 deficiency in a mouse model of pseudoxanthoma elasticum.
    Kauffenstein G; Pizard A; Le Corre Y; Vessières E; Grimaud L; Toutain B; Labat C; Mauras Y; Gorgels TG; Bergen AA; Le Saux O; Lacolley P; Lefthériotis G; Henrion D; Martin L
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1045-56. PubMed ID: 24675664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure.
    Schepelmann M; Yarova PL; Lopez-Fernandez I; Davies TS; Brennan SC; Edwards PJ; Aggarwal A; Graça J; Rietdorf K; Matchkov V; Fenton RA; Chang W; Krssak M; Stewart A; Broadley KJ; Ward DT; Price SA; Edwards DH; Kemp PJ; Riccardi D
    Am J Physiol Cell Physiol; 2016 Feb; 310(3):C193-204. PubMed ID: 26538090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD.
    Stanford SC
    Neuropharmacology; 2014 Dec; 87():9-18. PubMed ID: 24727210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha.
    Besnard S; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Tedgui A; Henrion D
    Circ Res; 2002 Apr; 90(7):820-5. PubMed ID: 11964376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3.
    Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM
    Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localisation and activation of the neurokinin 1 receptor in the enteric nervous system of the mouse distal colon.
    Pelayo JC; Veldhuis NA; Eriksson EM; Bunnett NW; Poole DP
    Cell Tissue Res; 2014 May; 356(2):319-32. PubMed ID: 24728885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurokinin-1 receptor-expressing cells regulate depressor region of rat ventrolateral medulla.
    Wang H; Weston MC; McQuiston TJ; Stornetta RL; Guyenet PG
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2757-69. PubMed ID: 12933345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockout of the Tachykinin Receptor 1 in the Mdr2
    Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
    Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.
    Huang H; Zhang X; Fu X; Zhang X; Lang B; Xiang X; Hao W
    Psychopharmacology (Berl); 2018 Oct; 235(10):2847-2857. PubMed ID: 30054674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of substance P in the marginal division of the neostriatum in learning and memory is mediated through the neurokinin 1 receptor in rats.
    Liu XM; Shu SY; Zeng CC; Cai YF; Zhang KH; Wang CX; Fang J
    Neurochem Res; 2011 Oct; 36(10):1896-902. PubMed ID: 21611833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased neuronal expression of neurokinin-1 receptor and stimulus-evoked internalization of the receptor in the rostral ventromedial medulla of the rat after peripheral inflammatory injury.
    Hamity MV; Walder RY; Hammond DL
    J Comp Neurol; 2014 Sep; 522(13):3037-51. PubMed ID: 24639151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurogenic tachykinin mechanisms in experimental nephritis of rats.
    Rodionova K; Hilgers KF; Paulus EM; Tiegs G; Ott C; Schmieder R; Schiffer M; Amann K; Veelken R; Ditting T
    Pflugers Arch; 2020 Dec; 472(12):1705-1717. PubMed ID: 33070237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis.
    Akasaka Y; Abe K; Sato T; Inoue H
    Neuropeptides; 2005 Oct; 39(5):467-74. PubMed ID: 16154193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
    Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
    Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice.
    Wang Q; Oyarzabal E; Wilson B; Qian L; Hong JS
    Clin Sci (Lond); 2015 Oct; 129(8):757-67. PubMed ID: 26223840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
    Koh YH; Moochhala S; Bhatia M
    J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.